51 results
Page 2 of 3
8-K
EX-4.10
f19v 9n9tjjkfx
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.2
0f28fs0 fsiawa
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
8-K
EX-4.4
per50q hlhw
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
8-K
EX-4.1
17ki7ze98ahp06ql
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
8-K
EX-4.3
yumrz14 jv0xznf3itr
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
8-K
EX-4.2
ss8xzotq6w3h0g5wh
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.3
nxn3tkt
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.1
kolviqkjqhg9 hgya6
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.1
j94ilj rie8b677kae4
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm